![EP 60: The Year 2021 in Review with Dr Sukh Nijjer – Part 1| recent cardiology trials](https://assets.radcliffecardiology.com/s3fs-public/podcast/2024-03/EP_60.png?VersionId=x8pIMdjzIO6UUET8mGUAqfsZqj.8weon)
In the last Parallax episode of the year,Dr Ankur Kalra welcomed back Dr Sukh Nijjer, Interventional Cardiologist from Imperial College London, to review the most impactful events and advances in cardiology from 2021.
This year we had a number of studies that helped clarify our understanding of the world of antiplatelets: First, Ankur and Sukh discuss the take-home messages from HOST-EXAM, a Korean study presented at ACC 2021. They discuss their clinical experiences within the UK and US setting. Next, Sukh talks about the STOPDAPT-2 ACS study, presented at ESC 2021. Sukh interprets the findings in the light of TWILIGHTand summarises his thoughts on the therapy.
2021 was not a great year for physiology: Sukh shares his take on FLOWER-MI, presented at ACC 2021. He offers a deep dive into the data and highlights both the importance of the findings and the limitations of the study.
Next, they discuss RIPCORD 2 from ESC 2021 and finally, Sukh highlights the findings from the FAME 3 trial.
What is the importance of genotype testing in the world of antiplatelets? What are the considerations for clinicians? Should we stop using FFR? How can we incorporate novel findings to patient care? What are the practical considerations that we should take into account when looking at the physiology trials of 2021?
Stay tuned for Part 2 - heart failure and surgical trials coming in 2022.
Questions and comments can be sent to “podcast@radciffe-group.com” and may be answered by Ankur in the next episode. Guest @SukhNijjer, hosted by @AnkurKalraMD. Produced by @RadcliffeCARDIO.
![Edwards: www.edwardstavr.com](https://assets.radcliffecardiology.com/article/2024-03/edwards_logo_v2_423_rgb_pos_jpg_3.jpg?VersionId=wvCe3eONeAb99zHg.28xvhD2n6mr2qy_)
Brought to you by Edwards: www.edwardstavr.com
![EP 61: The Year 2021 in Review with Dr Sukh Nijjer — Top Trials in Heart Failure and Cardiac Surgery](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2024-02/1920x1080_PP_EP61.png?VersionId=GBUOTD1Now0KlMBv1ZqsaenpUrh7dUtk&itok=ZyO2ze7u)
![EP 65: Industry Pathway ,“Who” Luck, and Thinking Big with Dr Shon Chakrabarti](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2024-02/1920x1080_Web_Artwork_Parallax_EP65.png?VersionId=ECpJyhiQ81TauD06gmFi0x5hPyPdZAMb&itok=YRL5dIF9)
![EP 64: Patient Advocate, CHD Care and the Mission of Team Uncle Joe with Joe Valente](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2024-02/1920x1080_Web_Artwork_Parallax_2022_0.png?VersionId=gBfQlPbRV1Jo1VR76XaBdCXvr4fNGvjp&itok=I9nEiYzP)
![EP 63: Innovation, Research, and the Concept of Hemorrhagic MI with Dr Rohan Dharmakumar](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2024-02/1920x1080_Web_Artwork_Parallax_2022.png?VersionId=DSOXwApj0IrcM1xYKfUv0f8.e6LEe_kh&itok=uJgbahtI)
![EP 62: Bullying, Harassment and Jealousy at Workplace with Dr Srihari S Naidu](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2024-02/1920x1080_EP62_PP.png?VersionId=iXp8vDsebm7W_M3eLJUYkC9b.ad5_mkb&itok=kLDg7s8y)
![EP 61: The Year 2021 in Review with Dr Sukh Nijjer — Top Trials in Heart Failure and Cardiac Surgery](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2024-02/1920x1080_PP_EP61.png?VersionId=GBUOTD1Now0KlMBv1ZqsaenpUrh7dUtk&itok=ZyO2ze7u)
![EP 60: The Year 2021 in Review with Dr Sukh Nijjer – Part 1| recent cardiology trials](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2024-02/1920x1080_PP_EP60.png?VersionId=5RD29a41Ka6RNtdDgzazifTh_tnmcFut&itok=vkisLegl)
![Parallax AHA Edition: 3 Trials that will change your practice with Dr Amit Khera](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2024-02/EP59_PP_1920x1080_Web_Thumbnail.png?VersionId=R.EhdsJ426kSouiUM7QobjhJoBxYBRuk&itok=x73s1klk)
![Parallax TCT Edition: 3 Trials that will Change Your Practice with Prof Mamas Mamas](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2024-02/PP_EP58_1920x1080_Web_Thumbnail.png?VersionId=wvsTjPMZ2PhW5QUtl9QIEj6FIS3xwS4A&itok=TzPo3hwm)
![Academic Success, Decision-making & Pragmatic Approach](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2024-02/EP57_PP_Social_Artwork2_0.png?VersionId=Z.tlaafPFucKKSQY1g6gOM5MfOLlPqI8&itok=kzt1-DFg)
![Parallax HFSA Edition: Diversity, Equity, Inclusion & Belonging with Dr Nancy M. Albert](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2024-02/EP56_PP_Social_Artwork2.png?VersionId=VZ0MM2neqFfUYaGSKTxejSWQQtSYxynC&itok=JfvloKdX)
![EP 55: 5 Interventional trials that will change your practice: Review of ESC 21 with Dr Mirvat Alasnag](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2024-02/EP55_PP_Social_Artwork2.png?VersionId=XqydymW5RgIx79bXep7IXBqs_.sPbpd.&itok=W6tcWoX7)
![EP 54: 5 Trials that will change your practice: Review of ESC 21 with Dr Purvi Parwani](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2024-02/EP54_PP_ESC_Social_Artwork2.jpeg?VersionId=CV84Bj0ufHo5zdvCiZG1ZpSelUUoSfS.&itok=6R4F__-9)
![EP 53: Belonging, Sparkplug & Purpose with Dr. Nasrien E. Ibrahim](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2024-02/EP53_PP_Social_Artwork2.png?VersionId=3cJpgCbgqjzkkFP4h_vpGeaUV0wtpP.N&itok=zNRF_yr4)
In this candid episode of Parallax, Nasrien and Ankur open up about their experiences of being an immigrant. Ankur asks Nasrien about her journey to medicine. Nasrien shares the lessons she took away from her years under the mentorship of Dr JoAnn Lindenfeld and later, Dr. James Januzzi. Finally, Nasrien shares her recent experience of writing Sparkplug and how she embraced life with its imperfections and found her purpose.
![Parallax HFSA Edition: Diversity, Equity, Inclusion & Belonging with Robert Mentz & Anuradha Lala](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2024-02/EP52_PP_Social_Artwork2.png?VersionId=LTwhYwKp5PzPtHQy1EGtfUugLNO.4H4p&itok=4d025YWH)
In this practical and insightful episode, Dr Kalra asks what does diversity, equity, inclusion and belonging mean to the editorial board of JCF and what were the steps taken to put these principles into practice.
![Industry Pathway, Misconceptions & Perspectives with Dr Sameer Bansilal](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2024-02/EP51_PP_Website_Thumbnail.png?VersionId=vWu8f0v7C6XfqkiV4eWzdn_qoIYEDWuh&itok=GBuxL24x)
Dr. Bansilal was an Assistant Professor of Medicine at the Icahn School of Medicine at Mount Sinai when he decided to seek an alternative pathway to make an impact on patients’ lives.